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Purinergic Signaling in Healthy and Diseased Skin
Geoffrey Burnstock1, Gillian E. Knight1 and Aina V.H. Greig2
Adenosine 50-triphosphate and adenosine receptors
have been identified in adult and fetal keratinocytes,
fibroblasts, melanocytes, mast cells, Langerhans cells,
and Meissner’s corpuscles, as well as in hair follicles,
sweat glands, and smooth muscle and endothelial
cells of skin vessels. Purinergic signaling is involved in
skin pathology, including inflammation, wound heal-
ing, pain, psoriasis, scleroderma, warts, and skin
cancer.
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INTRODUCTION
Extracellular purine nucleotides and nucleosides have
biological effects in a variety of cell and tissue types. The
majority of studies have been concerned with short-term
events that occur in neurotransmission and secretion (Burn-
stock, 2007a). Now, there is increasing evidence that
purinergic signaling can have long-term, trophic effects on
embryonic development, cell proliferation, differentiation,
and apoptosis (Abbracchio and Burnstock, 1998; Burnstock,
2002a, b; Burnstock and Verkhratsky, 2010).
Purinergic receptors
Purinergic receptors are classified into two groups: P1
receptors (selective for adenosine) and P2 receptors (selective
for adenosine 50-triphosphate (ATP), adenosine 50-diphos-
phate (ADP), and uridine 50-triphosphate (UTP), which act
as extracellular signaling molecules) (Burnstock, 1978).
Purinergic receptors are expressed in most neural and
nonneural cells (see Burnstock and Knight, 2004).
P1 receptors. Four members of the adenosine/P1 receptor
family have now been cloned and characterized from a
variety of species: A1, A2A, A2B, and A3, and selective
agonists and antagonists have been identified (Table 1). All
P1 receptors couple to G-proteins (Figure 1a), and modulate
adenylate cyclase activity in an inhibitory (A1, A3) or
stimulatory (A2A, A2B) fashion, resulting in cyclic adenosine
monophosphate (cAMP) changes.
P2 receptors. P2 receptors are divided into two families: P2X
and P2Y (Figure 1b and c), based on molecular structure,
transduction mechanisms, and pharmacological properties
(Burnstock and Kennedy, 1985; Abbracchio and Burnstock,
1994).
P2X receptors are ligand-gated ion channels, and are
activated by extracellular ATP to elicit a flow of cations
(Naþ , Kþ , and Ca2þ ) across the plasma membrane. Seven
subtypes of P2X receptors are recognized (Khakh et al., 2001)
(Table 2). All P2X receptors mediate fast signaling; however
their localization, function, and pharmacological character-
istics are different. Based on agonist efficacy and desensitiza-
tion characteristics, P2X receptors have been grouped into
three distinct classes. Group 1 includes P2X1 and P2X3
receptors with a high affinity for ATP (half-maximal effective
concentration (EC50)¼1 mM) that are rapidly activated and
desensitized. Group 2 includes P2X2, P2X4, P2X5, and P2X6
receptors that have a lower affinity for ATP (EC50¼10 mM),
and show slow desensitization and sustained depolarizing
currents. Group 3 is represented by the P2X7 receptor that has
very low affinity for ATP (EC50¼300–400 mM), shows little or
no desensitization, and, in addition to functioning as an ATP-
gated ion channel, can also function as a nonselective ion
pore (Di Virgilio et al., 1999).
Functional P2X channels are homomultimers or hetero-
multimers formed by the association of at least three subunits.
For a summary of possible P2X subunit combinations, see
Burnstock and Kennedy (2011). It is not yet known how the
properties of different P2X subunits influence the phenotype
of the heteromultimeric receptors. Alternative splicing
and species differences may increase heterogeneity of P2X
receptors.
The P2Y family of receptors is a subclass of the super-
family of G-protein-coupled receptors, each having seven
transmembrane domains. The third intracellular loop and the
C-terminus are thought to be involved in G-protein coupling,
whereas the third, sixth, and seventh transmembrane
domains have been implicated in nucleotide binding (Burn-
stock and Kennedy, 2011). The principal signal transduction
pathway of P2Y receptors involves phospholipase C, which
leads to the formation of inositol 1,4,5-triphosphate (InsP3)
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and mobilization of intracellular calcium. InsP3 regulates cell
growth and DNA replication (Berridge, 1987). Eight subtypes
of P2Y receptors have been described so far (Burnstock,
2007b) (Table 3).
Nucleotide ligands
ATP acts as a cotransmitter in many nerves of both peripheral
and central nervous systems. ATP is released together
with noradrenaline and neuropeptide Y from sympathetic
nerves. It is released as a cotransmitter with acetylcholine
from parasympathetic nerves supplying the bladder,
developing skeletal neuromuscular junctions and some
neurons in the brain. It is released with nitric oxide and
vasoactive intestinal polypeptide from nonadrenergic inhibi-
tory enteric nerves; with glutamate from primary afferent
sensory nerves and in different subpopulations of neurons in
the brain; with dopamine, noradrenaline, acetylcholine,
glutamate, g-aminobutyric acid, and 5-hydroxytryptamine.
Cotransmission offers subtle, local variations in neurotrans-
mission and neuromodulation mechanisms (Burnstock,
2009a).
Adenosine, AMP, ADP, and ATP can be released into the
extracellular environment during inflammation, wounding,
hypoxia, and other pathological states. There is a complex
relationship between these nucleotides. Extracellular ATP has
a very short half-life before it is degraded to adenosine (from
milliseconds to seconds depending on the site of release and
the level of activity of ectonucleotidases). AMP, ADP, and
ATP can be converted to adenosine through spontaneous
hydrolysis and/or through the activity of 50-ectonucleotidases,
ecto-ADPases, or ecto-ATPases. Adenosine can be converted
to inosine via the action of adenosine deaminase, or by
uptake into cells through nucleoside transporters. When
externalized, adenosine and its nucleotides can participate
in physiological processes. The rapid breakdown of ATP to
adenosine results in a multiplicity of different receptor sub-
types being activated, which can mediate different physiolog-
ical processes (e.g., proliferation, differentiation, migration,
Table 1. Summary of properties of P1 receptor subtypes in the skin
Receptor Site Agonist Antagonist Receptor properties
A1 Endothelial cells CCPA adenosine DPCPX, theophylline Reduces bradykinin and histamine-induced
vascular leakage
A2A Endothelial cells; neutrophils;
fibroblasts
CGS21680 adenosine Theophylline Endothelial cell proliferation; reduces
bradykinin and histamine-induced vascular
leakage; decreases oxygen free radical
production of neutrophils; increases
angiogenesis in wound healing; promotes
dermal collagen production by fibroblasts
A2B Keratinocytes; vascular smooth
muscle cells; human retinal
endothelial cells
Adenosine, NECA MRS1751, theophylline Antiproliferative in keratinocytes and vascular
smooth muscle cells; mediates VEGF expression
in retinal endothelial cells; promotes wound
healing
A3 Cl-IB-MECA MRE 3008F20 Not established
Abbreviations: CCPA, 2-chloro-N6-cyclopentyladenosine; DPCPX, 8-cyclopentyl-1,3-dipropylxanthine; NECA, 50-N-ethylcarboxamidoadenosine; VEGF,
vascular endothelial growth factor.
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Figure 1. Membrane receptors for extracellular adenosine and adenosine 50-
triphosphate (ATP). (a) The P1 family of receptors for extracellular adenosine
are G-protein-coupled receptors (S–S; disulfide bond). (b) The P2X family of
receptors are ligand-gated ion channels (S–S; disulfide bond; M1 and M2,
transmembrane domains), and (c) the P2Y family are G-protein-coupled
receptors (S–S; disulfide bond; green circles represent amino-acid residues
that are conserved between P2Y1, P2Y2, and P2Y3 receptors; fawn circles
represent residues that are not conserved; and red circles represent residues
that are known to be functionally important in other G-protein-coupled
receptors). Panel a is from Ralevic and Burnstock (1998); reproduced with
permission from the American Society for Pharmacology and Experimental
Therapeutics. Panel b is from Brake et al. (1994); reproduced with permission
from Nature. Panel c is modified from Barnard et al. (1994); reproduced with
permission from Elsevier.
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and cell death), and thus purines may act as important local
messengers in the skin.
This review article aims to give an overview of purinergic
signaling in cells in the skin, skin appendages, and then in
pathological processes affecting the skin.
KERATINOCYTES
P1 receptors
P1 receptors were first hypothesized to be present in the
epidermis in the 1970s. Adenosine, AMP, ADP, and ATP
activated adenylate cyclase in pig epidermis, resulting in
accumulation of cAMP. Theophylline, an adenosine receptor
antagonist, blocked the response to adenosine as well as to
the nucleotides (Iizuka et al., 1976), and hence it was thought
likely that responses to nucleotides were mediated by P1
receptors after enzymatic breakdown to adenosine.
Human keratinocytes express A2B receptor mRNA, but not
significant levels of A1, A2A, or A3 receptor mRNA. A2A
receptor stimulation promotes both proliferation and apo-
ptosis, whereas A3 stimulation arrests proliferation and
apoptosis (Merighi et al., 2002). Both primary cultures of
mouse keratinocytes and the murine keratinocyte cell line,
MSC-P5, express A2A, A2B, and A3 receptors, with A2B
receptors having the strongest expression. Stimulation of A2B
receptors resulted in enhanced growth (Braun et al., 2006).
Other studies have reported the antiproliferative effects of
adenosine nucleotides for both human and porcine kerati-
nocyte explants (see, e.g., Flaxman and Harper, 1975).
Table 2. Summary of properties of P2X receptor subtypes in the skin
Receptor Site Agonist Antagonist Receptor properties
P2X1 Smooth muscle; platelets a,b-meATP TNP-ATP, isoPPADS Rapidly desensitizing
P2X2 Smooth muscle; autonomic and sensory
ganglia
Weak agonists: 2-
MeSATP, b,g-meATP,
ATPgS
isoPPADS, Reactive Blue 2 Significant permeability to Ca2+; sensitive to
extracellular acidification
P2X3 Nociceptive sensory neurons (trigeminal,
nodose, and dorsal root ganglia);
endothelial and epithelial cells
a,b-MeATP TNP-ATP, isoPPADS Rapidly desensitizing
P2X4 CNS; testis; colon ATP TNP-ATP Slowly desensitizing
P2X5 Keratinocytes; growing hair follicles ATPgS PPADS, suramin
(nonselective)
Proliferating and differentiating cells in
keratinized and nonkeratinized epithelia
P2X6 CNS; motor neurons in spinal cord 2-MeSATP None Minimal desensitizing
P2X7 Apoptotic cells—e.g., keratinized
epithelium, macrophages, monocytes,
lymphocytes, granulocytes
BzATP KN-62, Coomassie Brilliant
Blue G
Bifunctional: either acts as cation channel or
forms a large pore and allows calcium entry
and cell death
Abbreviations: ADP, adenosine 50-diphosphate; ATP, adenosine 50-triphosphate; BzATP, 20,30-O-(4-benzoyl-benzoyl)-ATP; CNS, central nervous system;
a,b-meATP, a,b-methyleneATP; isoPPADS, pyridoxal-phosphate-6-azophenyl-20,50-disulfonic acid; 2-MeSADP, 2-methylthio ADP; 2-MeSATP, 2-methylthio
ATP; PPADS, pyridoxal-phosphate-6-azophenyl-20,40-disulfonic acid; TNP-ATP, 20,30-O-(2,4,6-trinitrophenyl)-ATP.
Table 3. Summary of properties of P2Y receptor subtypes in the skin
Receptor Site Agonist Antagonist Receptor properties
P2Y1 Epithelial and endothelial cells;
platelets; immune cells
ADP, ATP, 2-MeSADP MRS2179 Platelet aggregation; vascular relaxation;
endothelial cell proliferation
P2Y2 Epithelial cells; endothelial vascular
smooth muscle cells; immune cells
UTPgS, UTP, ATP PPADS, suramin Epithelial Cl secretion, vascular relaxation;
keratinocyte proliferation
P2Y4 Endothelial cells UTP, ATP PPADS Not established
P2Y6 Some epithelial cells; T cells UDP, UTP PPADS, suramin Not established
P2Y11 Granulocytes ATP Suramin Not established
P2Y12 Platelets ADP Suramin Platelet aggregation
P2Y13 Lymph nodes ADP, 2-MeSADP MRS2211, 2-MeSAMP Stimulation of MAPK; inhibition of adenylate
cyclase
P2Y14 Adipose tissue UDP glucose, UDP galactose Not known Chemoattractant and neuroimmune
functions
Abbreviations: ADP, adenosine 50-diphosphate; ATP, adenosine 50-triphosphate; MAPK, mitogen-activated protein kinase; 2-MeSADP, 2-methylthio ADP;
2-MeSAMP, 2-methylthio AMP; PPADS, pyridoxal-phosphate-6-azophenyl-20,40-disulfonic acid; UTP, uridine 50-triphosphate.
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Adenosine, ATP, and ADP were also shown to be anti-
proliferative for normal human epidermal keratinocytes
cultured in the absence or presence of exogenous epidermal
growth factor (Cook et al., 1995), probably via A2B receptors
(Brown et al., 2000). In this study, ATP had a more potent
effect than adenosine. The antiproliferative effect of adeno-
sine was not blocked by the A1/A2 receptor antagonist,
8-(p-sulfophenyl)theophylline, confirming the findings in a
previous study that used theophylline (Brown et al., 2000).
The adenosine transport blocking agent, dipyridamole, had
an inhibitory effect of its own and did not potentiate the effect
of adenosine. This suggested that extracellular adenosine
receptors were not being activated in this system. The effects
of adenosine might be mediated via an intracellular site of
action (Brown et al., 2000). 8-Chloro-adenosine, presumably
acting via P1 receptors, induced ‘‘growth arrest without
differentiation of primary mouse epidermal keratinocytes’’
(Dransfield et al., 2001).
In a study of the effect of various purinoceptor agonists on
primary human keratinocyte cultures, the response to ATP
was not blocked by 8-(p-sulfophenyl)theophylline, which
meant that the effect of ATP was not due to breakdown of
ATP to adenosine and activation of extracellular adenosine
receptors (Greig et al., 2003a). Dipyridamole did not
potentiate the ATP response, and hence blocking adenosine
transport into the cell, and thereby increasing local extra-
cellular adenosine concentrations, did not have any effect.
This suggests that the main trophic agent in human
keratinocyte cultures is ATP, working via P2 receptors,
whereas adenosine has a minor effect, which is largely
obscured by the ATP response.
P2 receptors
The presence of P2 purinergic receptors was suggested by
a study on canine keratinocytes (Suter et al., 1991).
Extracellular ATP stimulates P2 receptors to transiently
increase intracellular calcium levels. An increase in intracel-
lular calcium in cultured human keratinocytes is an early
event in terminal differentiation (Sharpe et al., 1989), which
is of primary importance during this process.
Proliferation. The first clue to a role for ATP in proliferation
came from the finding that ATP stimulates phosphoinositide,
which mobilizes [Ca2þ ]i, stimulates thymidine incorpora-
tion, thus inhibiting differentiation in cultures of human
epidermal keratinocytes (Pillai and Bikle, 1992). ‘‘In whole-
cell recordings from HaCaT cells,’’ an immortalized human
keratinocyte cell line, ATP ‘‘caused a bipolar change in
membrane potential, transient depolarisation followed by
long-lasting hyperpolarisation’’ (Koegel and Alzheimer,
2001). ‘‘Extracellular ATP stimulates HaCaT cell proliferation
via purinoceptor-mediated [Ca2þ ]i mobilization’’ (Lee et al.,
2001).
Reverse transcription-PCR and in situ hybridization studies
identified P2Y2 receptors on the basal layer of the epidermis,
which is the site of cell proliferation, and also identified P2Y2
receptors in primary cultured human keratinocytes. ATP and
UTP were equally effective in stimulating proliferation,
consistent with the pharmacological profile of P2Y2 receptors
(Dixon et al., 1999). This study also showed that cultured
human keratinocytes released ATP under static conditions.
Double labeling of human skin with proliferation markers
Ki-67, proliferating cell nuclear antigen, and P2Y1 and P2Y2
receptors, identified a proliferating subpopulation of basal
and parabasal keratinocytes. Cells positive for these two
markers were also positive for P2Y1 and P2Y2 receptors
(Greig et al., 2003a) (Figure 2). Low concentrations of ATP,
UTP, and 2-methylthio ADP caused an increase in keratino-
cyte cell number in primary human keratinocyte cultures,
also suggesting a role for P2Y1 and P2Y2 receptors in
keratinocyte proliferation (Greig et al., 2003a). Further
evidence has demonstrated functional P2Y1, P2Y2, and
P2Y4 receptors in human keratinocytes, which are involved
in the regulation of cell proliferation (Burrell et al., 2003).
Costimulation of HaCaT cells by ATP acting on P2Y2
receptors and parathyroid hormone–related protein increased
proliferation (Burrell et al., 2008). Confocal optical sectioning
through mulilayered HaCaT cultures showed that the
responsiveness to ATP differs dramatically between prolifer-
ating cells and cells undergoing partial differentiation
(Burgstahler et al., 2003). It was claimed that UTP caused
IL-6 production in HaCaT keratinocytes via P2Y2 and/or P2Y4
receptors (Kobayashi et al., 2006; Yoshida et al., 2006). This
finding might be important as studies have shown that IL-6
has a physiological role in the repair processes of wounds
(Gallucci et al., 2000). Calcium-permeable transient receptor
potential canonical 7 is a purinoceptor-operated 1,2-diacyl-
gycerol-activated channel in HaCaT cells (Beck et al., 2006),
thought to be an additional mediator of calcium influx into
keratinocytes, which in turn can lead to differentiation.
‘‘Calcium-independent phospholipase A is required for Ca2þ
entry into HaCaT keratinocytes following ATP or UTP
stimulation’’ (Ross et al., 2007, 2008), and Ca2þ movement
is involved in the control of numerous cellular process.
‘‘Retinoids, vitamin A derivatives, are important regulators
of growth and differentiation of skin cells’’ and have been
used therapeutically for aging skin. An agonist for the retinoic
receptor was shown to enhance expression of mRNA for P2Y2
receptors in basal keratinocytes involved in proliferation of
the epidermis (Fujishita et al., 2006).
Differentiation. Changes in intracellular Ca2þ were found to
regulate differentiation of keratinocytes in the granular layer
of the epidermis (Menon et al., 1985), which is an interesting
observation in view of the later discovery of high expression
of P2X5 receptors in this layer of the epidermis, the
purinoceptor subtype that is known to mediate cell differ-
entiation (Gro¨schel-Stewart et al., 1999; Greig et al., 2003a).
Double labeling of P2X5 receptors with cytokeratin K10 or
involucrin showed that P2X5 receptors were expressed
in differentiating keratinocytes within the epidermis (Greig
et al., 2003a). The increase in [Ca2þ ]i in response to
ATP varied in each layer of the epidermis and was greater
in the basal than in the outer layers (Tsutsumi et al., 2009a).
Both extracellular ATP and UTP ‘‘induce transient rises in
cytosolic free Ca2þ ’’ in both human and canine keratinocytes
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(Sharpe et al., 1989; Suter et al., 1991), suggesting in
retrospect that P2Y2 and/or P2Y4 receptors were involved.
Multiple P2X receptor subtypes were identified later in
cultured human epidermal keratinocytes using whole-cell
patch clamp techniques, reverse transcription-PCR, and
intracellular Ca2þ measurements (Inoue et al., 2005). P2X2,
P2X3, P2X5, and P2X7 receptor mRNA was increased in
differentiated cells, whereas P2Y2 receptor mRNA was
downregulated in differentiated cells.
Protein kinase C-a has been shown to decrease cell
proliferation and augment cell differentiation of human
keratinocytes (Hegemann et al., 1994). The expression of
P2X7 receptors was significantly increased in keratinocytes
overexpressing protein kinase C-a (Go¨nczi et al., 2008).
Terminal differentiation/apoptosis. An immunohistochem-
ical study of rat stratified squamous epithelium showed that
P2X7 receptors were clearly associated with the keratiniza-
tion process in the outer layer (Gro¨schel-Stewart et al., 1999).
This was confirmed in human epidermis with colocalization
with markers for keratinocyte apoptosis: P2X7 receptors
control death of keratinocytes in the outer stratum corneum
(Greig et al., 2003a). The P2X7 receptor is unlike other P2X
receptors because it is a bifunctional molecule that can be
triggered to act as a channel permeable to small cations, or
on prolonged stimulation can form a cytolytic pore perme-
able to large hydrophilic molecules up to 900Da (Surprenant
et al., 1996). The opening of this pore results in the increase
in intracellular cytosolic free calcium ions and the induction
of cell death (Zheng et al., 1991; Ferrari et al., 1996). There is
evidence that this process is dependent on the caspase
signaling cascade (Coutinho-Silva et al., 1999; Ferrari et al.,
1999). Double labeling of P2X7 receptors with anti-caspase-3
showed colocalization within the stratum corneum (Greig
et al., 2003a) (Figure 2f). High concentrations of ATP and
20,30-O(benzoyl-4-benzoyl-ATP) (BzATP, a P2X7 receptor
agonist) caused a significant decrease in keratinocyte cell
number in primary human keratinocyte cultures, providing
evidence for a functional role for P2X7 receptors (Greig et al.,
2003a).
Fetal keratinocytes
The expression of P2X5, P2X7, P2Y1, and P2Y2 receptors in
8–11-week-old human fetal epidermis was investigated using
immunohistochemistry (Greig et al., 2003b). P2 purinergic
receptors are likely to be involved in fetal keratinocyte
proliferation via P2Y1 receptors found on basal cells and fetal
keratinocyte differentiation via activation of P2X5 receptors.
Figure 2. Double labeling of P2Y1 and P2Y2 receptors with markers of
proliferation show colocalization within a subpopulation of basal and parabasal
keratinocytes. Double labeling of P2X5 receptors with markers of differentiated
keratinocytes show colocalization within the stratum spinosum, and double
labeling of P2X7 receptors with markers of apoptosis in human leg skin show
colocalization within the stratum corneum. (a) Ki-67 immunolabeling (a marker
for proliferation) stained the nuclei (green) of a subpopulation of keratinocytes in
the basal and parabasal layers of the epidermis. P2Y1 receptor immunostaining
(red) was found in the basal layer on cells also staining for Ki67. Scale
bar¼30mm. (b) Proliferating cell nuclear antigen (PCNA) immunolabeling
(a marker for proliferation) stained the nuclei (green) of a subpopulation of
keratinocytes. These nuclei were often distributed in clusters and found in the basal
and parabasal layers of the epidermis. P2Y2 receptor immunostaining (red) was
also expressed in basal and parabasal epidermal cells. Scale bar¼ 30mm. (c) P2X5
receptor immunostaining (red) showed overlap (yellow) with cytokeratin K10
(green), an early marker of keratinocyte differentiation. P2X5 receptors were
present in the basal layer of the epidermis up to the mid-granular layer. Cytokeratin
K10 was distributed in most suprabasal keratinocytes. The stratum basale stained
only for P2X5 receptors, indicating that no differentiation was taking place in these
cells. The colocalization of P2X5 receptors and cytokeratin K10 appeared mainly
in the cytoplasm of differentiating cells within the stratum spinosum and partly in
the stratum granulosum. Note that the stratum corneum also stained for cytokeratin
K10, which labeled differentiated keratinocytes, even in dying cells. Scale
bar¼30mm. (d) P2X5 receptor immunostaining (red) showed overlap (yellow)
with involucrin (green). P2X5 receptors were present in the basal layer of the
epidermis up to the midgranular layer. Note that the pattern of staining with
involucrin was similar to that seen with cytokeratin K10, except that cells from the
stratum basale up to the midstratum spinosum were not labeled with involucrin,
which is a late marker of keratinocyte differentiation. Scale bar¼ 30mm.
(e) TUNEL (green) labeled the nuclei of cells at the uppermost level of the stratum
granulosum and P2X7 antibody (red) mainly stained cell fragments within the
stratum corneum. Scale bar¼15mm. (f) Anti-caspase-3 (green) colocalized with
areas of P2X7 receptor immunostaining (red) both at the junction of the stratum
granulosum and within the stratum corneum. Areas of colocalization are yellow.
Note that the differentiating keratinocytes in the upper stratum granulosum were
also positive for anti-caspase-3. Bar¼ 15mm (reproduced fromGreig et al., 2003a,
with permission of the Nature Publishing Group).
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Double labeling of P2X7 receptors with anti-caspase-3
showed colocalization within the periderm. The periderm is
known to exhibit characteristics consistent with apoptosis
(Kerr et al., 1972) before its loss from the epidermis
(Polakowska et al., 1994), which occurs at midgestation
(20–24 weeks). P2X7 receptors are likely to be part of this
apoptotic process and the expression of P2X7 receptors is
important in the regulation of apoptosis intrinsic to correct
development. P2Y2 receptors were also found only in
periderm cells and there was no colocalization with
proliferation markers proliferating cell nuclear antigen and
Ki67 in the periderm cells. The role of P2Y2 receptors is
currently unknown (Greig et al., 2003b).
Trophic effects in response to mechanical stimulation and heat
Mechanical stimulation of human epidermal keratinocytes
causes release of ATP, which then activates P2Y2 receptors to
induce Ca2þ waves (Koizumi et al., 2004; Tsutsumi et al.,
2009b; Azorin et al., 2011) (Figure 3). When keratinocytes
are cocultured with dorsal root ganglion (DRG) neurons, an
increase in [Ca2þ ]i occurs in adjacent neurons, suggesting
ATP-mediated crosstalk between keratinocytes and sensory
nerves. The epidermis acts as a physical barrier between the
organism and its environment. It is innervated by unmyeli-
nated sensory nerve fibers conveying nociceptive and
thermoceptive information. ‘‘Trophic effects of keratinocytes
(perhaps releasing ATP) on axonal development of sensory
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Figure 3. Increases in [Ca2þ ]i evoked by both applied adenosine 50-triphosphate (ATP) and uridine 50-triphosphate (UTP) in normal human epidermal
keratinocytes (NHEKs). (a) Sequential pseudo-color images of Ca2þ responses to 100 mM ATP (A) and UTP (B) in NHEKs. Images were obtained from a
confocal laser microscope, showing self-ratios of fluo-4 fluorescence. Images were recorded 2 seconds before (2 seconds) and 2, 10, and 20 seconds after
ATP or UTP application. (b) Concentration–response curves for (A) ATP- and (B) UTP-evoked increases in [Ca2þ ]i in NHEKs. Increases in [Ca
2þ ]i in NHEKs
were monitored by ratiometric fura 2 fluorescence (DF340/F360) and were then converted into absolute value of [Ca
2þ ]i using a standard calibration curve.
The maximum [Ca2þ ]i increase was observed when cells were stimulated with 300 mM ATP (A) or UTP (B). The increase in [Ca
2þ ]i at each ATP or UTP
concentration was normalized by the maximum increase in [Ca2þ ]i. Results are the means±SEM for 28–73 cells tested. Both the ATP- and UTP-evoked
concentration–response curves were almost identical with the half-maximal effective dose (ED50) values of 21 and 20 mM, respectively (reproduced from Koizumi
et al., 2004, with permission of Portland Press Limited).
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neurons have been described in a coculture model’’ (Ulmann
et al., 2007).
Thermal information detected by the skin layers is
converted into electrical signals and transmitted to the central
nervous system. Transient receptor potential V (TRPV) 3 and
TRPV4 are heat-activated cation channels expressed by
keratinocytes. Evidence has been presented that ATP is
‘‘released from keratinocytes upon heating’’ and that ‘‘ATP is
a messenger molecule for TRPVR3-mediated thermotrans-
duction in skin to sensory nerve activation’’ (Mandadi et al.,
2009).
Chronic venous insufficiency
In chronic venous insufficiency, there is a thinning of the
epidermis and changes in purinoceptor subtype expression
have been found. P2Y1 and P2Y2 receptor expression was
found to increase in the basal and spinosal layers, whereas
P2X5 receptor expression increased mainly in the spinosal
layer and extending further into the stratum granulosum. In
contrast, P2X7 receptor expression was shown to be reduced
in the stratum corneum (Metcalfe et al., 2006). These
receptors are possible targets for manipulating skin to avoid
ulcers, one of the consequences of venous insufficiency.
ENDOTHELIAL CELLS
There is evidence for P2Y1, P2Y2, and P2Y4 receptor subtypes
on vascular endothelial cells, which are involved in mediat-
ing the release of nitric oxide, and causing subsequent
vasodilatation (Burnstock, 2002a). Endothelial cells release
ATP (Pearson and Gordon, 1979; Bodin et al., 1991), and it
has been suggested that ATP released from vascular
endothelial cells causes an autocrine mitogenic stimulation
of endothelial cells (Burnstock, 2002a). Adenosine can also
stimulate vascular endothelial cell proliferation (Van Daele
et al., 1992) and DNA synthesis (Ethier and Dobson, 1997).
Adenosine A2A receptors have been shown to mediate
endothelial proliferation in human umbilical veins via
activation of mitogen-activated protein kinase (Sexl et al.,
1995). Adenosine also mediates vascular endothelial growth
factor expression via A2B receptors in human retinal
endothelial cells (Grant et al., 1999), and A2B receptor
antagonists inhibit proliferation of human retinal endothelial
cells stimulated by the adenosine analog NECA (50-N-
ethylcarboxamidoadenosine) (Grant et al., 2001). Adenosine
may also act independently from adenosine receptors. In
bovine aortic endothelial cells, the mitogenic action of
adenosine was resistant to the adenosine receptor antagonist,
8-phenyltheophylline, and was not mimicked by A1 and A2
selective agonists (Van Daele et al., 1992).
LANGERHANS CELLS
Langerhans cells are bone marrow–derived dendritic cells in
the epidermis that express Ca2þ /Mg2þ ATPase (Chaker et al.,
1984; Carrillo-Farga et al., 1991). ATP has been implicated in
Langerhans cell chemotaxis, probably as a facilitator (Kimber
et al., 2000). Human and mouse epidermal Langerhans cells
‘‘express functional P2X7 receptors’’ (Georgiou et al., 2005;
Tran et al., 2010). BzATP can stimulate ethidiumþ uptake
into Langerhans cells in wild-type mice and this was used as a
measure of P2X7 function. BzATP did not stimulate
ethidiumþ uptake into Langerhans cells in P2X7-deficient
mice (Tran et al., 2010). ATP has a role in the involvement
of Langerhans cells in adaptive immunity (Holzer and
Granstein, 2004). ATPgS has been found to enhance the
antigen-presenting ability of mouse Langerhans cells, and a
Langerhans cell line (XS106) was shown to express mRNA
for P2X1, P2X7, P2Y1, P2Y2, P2Y4, and P2Y11 receptors
(Granstein et al., 2005), although it was not clear which
receptor subtype(s) was responsible for this effect.
DERMAL FIBROBLASTS
It was shown that upon exposure to ATP, dermal fibroblasts
contract (Ehrlich et al., 1986). Subsequently, dermal fibro-
blasts have been shown to express P2X7 and a P2Y-like
receptor (Solini et al., 1999). Adenosine, probably acting via
A2 receptors, increased proliferation of human skin fibro-
blasts in primary cultures (Thellung et al., 1999). Adenosine
has been used as a topical application to reduce wrinkles
(Legendre et al., 2007), perhaps by promoting collagen
production by dermal fibroblasts via the adenosine A2A
receptor (Chan et al., 2006).
MEISSNER’S CORPUSCLES
The glabrous skin of mammals is supplied by many primary
afferents that have rapidly adapting responses with sharply
defined receptive folds. It is claimed that these responses are
mediated through Meissner’s corpuscles. In the glabrous skin
of monkey digits, there are at least three types of sensory
innervation, including C-fibers that are sensitive to ATP (Pare´
et al., 2001).
MELANOCYTES
There is relatively little information about purinoceptors on
melanocytes. However, a study has shown that phenolic skin
bleaching agents upregulate adenosine A2B receptors, the
stimulation of which resulted in melanocyte apoptosis (Le
Poole et al., 1999).
HAIR FOLLICLES
The cells of the lower portion of the hair follicle bulb are
undifferentiated matrix cells. These are rapidly dividing cells
that give rise to eight different cell lineages, including
medulla, cortex, and hair cuticle cells that make up the hair
shaft; the inner root sheath that is made up of the inner root
sheath cuticle, and Huxley’s and Henle’s layers; the
companion layer; and the outer root sheath (Niemann and
Watt, 2002). The hair cycle is divided into periods of hair
growth (anagen), followed by a regression phase (catagen)
when the lower part of the hair follicle undergoes
programmed cell death, and a resting phase (telogen) before
the onset of a new growth phase. Using immunohistochem-
istry, it was shown that P2X5, P2Y1, and P2Y2 receptors were
expressed in spatially distinct zones of the anagen hair
follicle: P2Y1 receptors in the outer root sheath and bulb
mediate keratinocyte proliferation; P2X5 receptors in the
inner and outer root sheaths and medulla are associated with
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differentiation; and P2Y2 receptors in living cells at the edge
of the cortex/medulla are involved in proliferation (Greig
et al., 2008).
‘‘An adenosine receptor-mediated signal transduction
pathway in hair dermal papilla cells contributes to minox-
idil-induced hair growth’’ (Li et al., 2001; Iino et al., 2007).
Microarray analysis of dermal papilla showed that adenosine,
via A2B receptors stimulation, increased ‘‘fibroblast growth
factor-7 gene expression levels by greater than 2-fold,’’
suggesting that adenosine might stimulate hair growth
through fibroblast growth factor-7 upregulation in dermal
papilla (Iino et al., 2007). Adenosine was shown to increase
anagen hair growth and thicken hairs in women with female
pattern hair loss in a double-blind, randomized, placebo-
controlled trial (Oura et al., 2008). Adenosine is also effective
in increasing hair diameter and density in male pattern hair
loss (Iwabuchi et al., 2009).
SWEAT GLANDS
The sweat gland consists of the secretory coil where sodium
chloride–rich primary sweat is produced and a duct where
part of the sodium and chloride is reabsorbed. Sweat glands
are classified into apocrine and eccrine types, even though
the mechanics of sweat secretion are probably the same.
Apocrine glands arise from hair follicles, whereas eccrine
glands arise from the epidermis.
ATP was shown to evoke increased chloride permeability
in cultured sweat gland epithelial cells of horses (Wilson
et al., 1993). UTP, as well as ATP, regulates [Ca2þ ]i,
indicating mediation by P2Y2 and/or P2Y4 receptors (Ko
et al., 1994; Wilson et al., 1995). Apical (but not basolateral)
application of ATP and UTP stimulates chloride and
bicarbonate secretion in equine sweat gland epithelial cells
(Ko et al., 1997), probably via P2Y2 and/or P2Y4 receptors
(Wilson et al., 1998). Both the purinergic and b-adrenergic
pathways for control of sweat secretion from the equine
sweat gland are impaired in anhidrosis (Wilson et al., 2007).
In contrast, hyperhidrotic eccrine sweat glands from humans
showed a wider distribution of P2Y2 receptors compared with
normal glands and may play a role in this condition (Lindsay
et al., 2002b). A review article is available about equine
sweating and anhidrosis, which includes a discussion of the
source and roles of nucleotides (McEwan Jenkinson et al.,
2006).
Calcium-activated chloride fluxes have been demon-
strated in the human sweat gland cell line, NCL-SG3, and
ATP is shown to increase the inward current (Ring et al.,
1995). Electrophysiological studies showed that monolayers
of the NCL-SG3 cell line respond to ATP with a transient
transepithelial potential change with a more pronounced
response to apical than basal application (Ring and Mo¨rk,
1997). Extracellular ATP, but not UTP, via P2Y receptors,
caused a decrease in Cl and Kþ in primary cultures of
reabsorptive ducts of human sweat glands studied with X-ray
microanalysis (Hongpaisan and Roomans, 1998). However,
the same group showed that both UTP and ATP regulated
Naþ , Cl, and Kþ transport in primary cultures of human
sweat gland coils (Hongpaisan and Roomans, 1999).
Immunolocalization of P2Y1, P2Y2, and P2Y4 receptor
subtypes was later described in human eccrine sweat glands
(Lindsay et al., 2002a). These receptors were found on
myoepithelial-like cells, whereas P2Y1 and P2Y2 immuno-
staining was seen on the apical membranes of secretory cells
(Lindsay et al., 2008). Sympathetic nerves control sweat
gland secretion and probably glandular growth and plasticity;
as ATP is a cotransmitter in sympathetic nerves, it is likely to
participate in these events.
SKIN VESSELS
Thermally induced reflex changes in blood flow through
arteriovenous anastomoses in rabbit ear arteries were shown
to be mediated by sympathetic nerves and the possibility that
purinergic transmission might be involved in the changes in
blood flow was raised (Hales et al., 1978). In dogs and cats, a
nonadrenergic, noncholinergic vasodilator response to nerve
stimulation was revealed following pretreatment with gua-
nethidine, which abolished the vasoconstrictor effects of
sympathetic nerve stimulation (Bell et al., 1985). There is
evidence that degranulation of mast cells in the skin is
produced by ATP, released during antidromic impulses from
sensory nerve endings during axon reflexes, leading to
vasodilation of skin vessels (Kiernan, 1975). Denervation of
sensory motor nerves of skin was shown to be followed by
hypersensitivity to ATP (Kiernan, 1974).
Cold-induced neurogenic vasoconstriction of canine
cutaneous veins appears to be mediated largely by an
increase in the component of purinergic sympathetic
transmission (Flavahan and Vanhoutte, 1986). In a later
paper, it was suggested that cooling-induced reduction in
skin blood flow was because of the ATP released from
sympathetic nerves stimulating presynaptic P2 receptors on
sympathetic nerve terminals to facilitate release of noradrena-
line, resulting in constriction (Koganezawa et al., 2006).
When skin temperature was increased, A1 receptors mediated
vasodilation (Stojanov and Proctor, 1990). Pharmacological
evidence has been presented for both high-affinity A1
receptors and low-affinity A2 receptors, with adenosine
mediating vasoconstriction below 108 M and vasodilation
above 106 M in hamster skin circulation (Stojanov and
Proctor, 1989).
Isolated human subcutaneous resistance arteries were
shown to dilate via P2Y and P1 receptors, but constrict via
P2X receptors (Martin et al., 1991). Intra-arterial infusion of
ATP, ADP, and AMP in canine facial and nasal vascular beds
caused vasodilation (Bari et al., 1993). Intra-arterial infusion
of ATP can improve ischemic skin flap survival (Boss et al.,
1984; Cikrit et al., 1984; Zimmerman et al., 1987; Knight
et al., 1989), perhaps because of its vasodilator effects (Kuzon
et al., 1985). Deep lingual arteries in the monkey tongue are
innervated by b-adrenergic and purinergic components of
sympathetic nerves, both producing vasoconstriction (Toda
et al., 1997). Transmural nerve stimulation caused contrac-
tion followed by vasodilation of the labial artery close to the
skin of the upper lip of dogs; the contraction was abolished
by a combination of prazosin (an a1 adrenoceptor antagonist)
and a,b-methyleneATP (a,b-meATP; a P2X receptor agonist
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that desensitizes receptors with repeated exposure), whereas
the relaxation was abolished by the nitric oxide synthase
inhibitor, NG-nitro-L-arginine methyl ester (Okamura et al.,
1999).
SKIN PATHOLOGY
Psoriasis
This is a chronic skin disease with hyperproliferation in the
epidermis in involved areas. Costimulation with parathyroid
hormone–related protein and ATP increased proliferation in
HaCaT cells and may be a mechanism for the hyperprolifera-
tion that occurs in psoriasis (Burrell et al., 2008). P2Y2
receptors play a major role in epidermal homeostasis and
may provide a new target for therapy of proliferative disorders
of the epidermis, including psoriasis (Dixon et al., 1999). In
psoriatic epidermis, intense P2X7 receptor expression was
found to be confined to the cell membrane of the basal layer,
whereas P2Y1 receptors were found throughout the epidermis
(Pastore et al., 2007). This suggests that P2Y1 and P2X7
receptors have a role in skin inflammation, and this is also
supported by the finding that they are the only P2 receptors
upregulated by IFN-g and that immunoreactivity for these
receptors was enhanced in the lesional skin of patients with
psoriasis (Pastore et al., 2007).
High levels of adenosine in the blood of psoriasis patients
have been reported. ‘‘Adenosine increased cAMP levels in
lesioned and uninvolved areas of epidermis obtained from
psoriasis patients’’ (Duell, 1980). A defective purine nucleo-
tide synthetic pathway has been described in psoriasis
patients (Kiehl and Ionescu, 1992) and nucleotide metabo-
lism is altered in psoriatic keratinocytes (Mahrle and Orfanos,
1975). The ability to incorporate [H3]adenine into ATP and
adenyl cyclase activity was significantly lower in psoriasis
plaques than in uninvolved skin and lower than in normal
skin of control subjects (Mui et al., 1975). Decreased
membrane-bound ATP-hydrolytic activity was reported in
psoriatic epidermis (Mahrle and Orfanos, 1974).
Adenosine deaminase activity is a nonspecific marker of
T-cell activation. T-cell activation is thought to play an
important role in the pathogenesis of psoriasis. In psoriasis
patients, serum as well as epidermis, adenosine deaminase
levels were significantly elevated (Bu¨ku¨lmez et al., 2000) and
may reflect the accelerated salvage pathways of nucleic acid
metabolism associated with the hyperproliferative epidermis
(Koizumi et al., 1983). Based on the results of a trial, it was
concluded that caffeine, a P1 adenosine receptor antagonist,
‘‘is an effective, safe and inexpensive treatment for psoriasis’’
(Vali et al., 2005), as in psoriatic epidermis, the level of
cAMP decreases and caffeine increases concentrations of
intracellular cAMP.
Scleroderma
The term scleroderma encompasses a spectrum of disorders
that includes localized scleroderma (morphea), which mainly
causes dermal fibrosis and systemic sclerosis (SSc). SSc is a
rare, severe disease involving the connective tissue of
affected organs, including in particular the skin, gastrointes-
tinal tract, lung, heart, and kidney. The disease hallmark is an
overproduction and accumulation of collagen and other
extracellular matrix proteins, resulting in fibrosis and tissue
dysfunction. Adenosine A2A receptors play an active role in
the pathogenesis of dermal fibrosis and suggest a new
therapeutic target for the treatment and prevention of dermal
fibrosis in scleroderma (Chan et al., 2006; Ferna´ndez et al.,
2008; Chan and Cronstein, 2010). Skin biopsies from patients
affected by the diffuse form of SSc were examined (Lo
Monaco et al., 2007). Fibroblasts from patients with SSc had a
high rate of spontaneous IL-6 release, which was further
enhanced by stimulation with ATP. Changes in intracellular
ion homeostasis ([Ca2þ ]i) and plasma membrane potential
occurred at much lower ATP concentrations in fibroblasts
from patients with SSc than in those from healthy controls.
Analysis of Ca2þ influx versus Ca2þ release showed that
both processes occurred at lower ATP concentrations in SSc
fibroblasts. ATP-stimulated fibroblasts from patients with SSc
underwent morphological alterations that did not occur in
fibroblasts from healthy controls (Lo Monaco et al., 2007).
SSc fibroblasts expressed mRNA for several P2 receptors:
P2Y1, P2Y2, P2Y4, P2Y6, P2X3, P2X4, and P2X7. This suggests
a potential therapeutic role for P2 receptor antagonists in
patients with SSc via a possible modulatory effect on
fibroblast function.
Hailey–Hailey and Darier diseases
These are autosomal dominant skin disorders, characterized
by dissociation of epidermal keratinocytes (acantholysis) at
the suprabasal layer of the epidermis. In lesions examined,
P2Y2 receptors were not localized in acantholytic cells, but
P2X7 receptors appeared in the plasma membranes, poten-
tially mediating apoptosis (Leinonen et al., 2009).
Warts
Warts arise because human papillomavirus (HPV) infect the
basal keratinocyte of the epidermis, presumably through
disruptions of the skin or mucosal surface (Cook and McKee,
1989). The virus remains latent in basal cells as a circular
episome. As keratinocytes differentiate and migrate to the
surface, the virus is triggered to undergo replication and
maturation. Hybridization studies in situ of HPV lesions have
shown that viral DNA synthesis occurs in the skin in the
superficial stratum spinosum and full virus assembly with
capsid production occurs in the stratum granulosum. In warts,
there is a prominent granular cell layer, within which there
are vacuolated cells called koilocytes, characteristic of HPV
infection. The process of virus replication alters the character
of the epidermis, resulting in cutaneous or mucosal excres-
cences known as warts.
In warts, P2X5 receptor staining was increased compared
with that in normal skin (Greig et al., 2006). There were few
P2X5 receptor–positive cells in the basal layer, with most of
the positively stained cells being in the suprabasal layers.
P2X5 receptors were found in the nuclei of koilocytes,
indicating that these receptors were present in an abnormal
location in virus-infected cells, because they were usually
found in the cytoplasm and cell membrane. In CIN 612 (HPV
31) raft cultures, P2X5 receptors were found in all cell layers
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and the level of staining was more intense than in the normal
keratinocyte raft cultures.
In normal human skin, P2X7 receptor immunoreactivity
was solely associated with cells and cell fragments within the
stratum corneum (Greig et al., 2003a). In raft cultures of
normal human foreskin keratinocytes, P2X7 receptor staining
was very weak compared with normal skin. This may be
because of the phenomenon of incomplete differentiation
that occurs in raft cultures, thought to be associated with the
presence of retinoids in the medium (Kopan et al., 1987). In
warts, P2X7 immunoreactivity was associated with hyperker-
atotic areas of the stratum corneum, as well as in the nuclei of
koilocytes in the suprabasal layers. The nuclei that were
positive for P2X7 receptors were not normal: nuclei were
shrunken, with much more intense P2X7 receptor staining. In
CIN 612 raft cultures, P2X7 immunoreactivity was positive in
both the cell cytoplasm and nucleus of HPV-infected cells. It
is possible that the presence of P2X7 receptors in the nucleus
of HPV-infected cells indicates a severe disruption of the
cellular machinery. It might be possible to use P2X7 receptor
agonists to trigger apoptosis in these virally infected cells.
P2X5 and P2X7 receptors may provide a useful focus for more
research into new treatment modalities for warts and
squamous cell carcinomas because these receptors can
induce cell differentiation as well as cell death. Vegetative
reproduction of HPV particles can only take place in highly
differentiated keratinocytes. Raft organotypic cultures of both
normal human keratinocytes and HPV-infected cells could
prove to be a useful tool for further study of these receptors
in vitro.
Skin inflammation
The skin is a highly specific immune defense organ. Physical,
chemical, or immune-specific insults rapidly evoke cellular
responses, characterized by an increased expression of a
wide range of proinflammatory mediators and, in particular,
keratinocytes release chemokines. Inflammation of the skin
can be promoted in a variety of different ways, and is
associated with release of ATP, increase in expression of
purinoceptors, particularly the P2X7 and perhaps P2Y1
receptor subtypes, and subsequent release of proinflamma-
tory cytokines (see Inoue et al., 2007; Pastore et al., 2007).
The possibility has been raised that ‘‘P2 receptor antagonists
may reduce skin inflammation’’ (Inoue et al., 2007). A recent
DNA microarray analysis has shown that ATP induces IL-6,
IL-20, ATF3 (activating transcription factor 3), and CXCL1
(chemokine (C-X-C motif) ligand 1) production, and phos-
phorylates STAT3 (signal transducer and activator of tran-
scription 3) (Ohara et al., 2010). The authors claim that
through these mechanisms, ATP plays a crucial role in wound
healing, the defense response, innate immunity, and inflam-
mation in the skin, and may be a key player in psoriasis.
Irritant chemicals trigger rapid release of ATP from
keratinocytes and cause exacerbated skin inflammation in
ectonucleotidase (CD39) knockout mice (Mizumoto et al.,
2002). Sulfur mustard–induced cytotoxicity of human epi-
dermal keratinocytes is prevented by the P2 receptor
antagonist suramin (Doebler, 2003). A recent paper claimed
that UV radiation evokes ATP release from keratinocytes and
that P2Y6 receptors mediate UV radiation–induced inflam-
matory responses of keratinocytes (Takai et al., 2011).
Purinergic agonists (ATP and ATPgS) induce release of
inflammatory mediators from human dermal microvascular
endothelial cells (Bender et al., 2008). Intradermal adminis-
tration of ATPgS results in an enhanced contact hypersensi-
tivity response in mice, and it was suggested ‘‘that ATP, when
released after trauma or infection, may act as an endogenous
adjuvant to enhance the immunoresponse and that P2
receptor agonists may augment the efficacy of vaccines’’
(Granstein et al., 2005). ‘‘Purinergic receptor expression on
keratinocytes reflects their function on the epidermis during
chronic venous insufficiency’’ (Metcalfe et al., 2006).
Evidence was presented ‘‘that A1 and A2 (but not A3)
receptors may function as cutaneous neurogenic pro-inflam-
matory mediators’’ (Esquisatto et al., 2001). Human skin
keratinocytes attacked by Staphylococcus aureus, which
releases a-toxin, showed a transient drop in cellular ATP
levels (Suriyaphol et al., 2009).
Allergy
Sensitization to contact allergens requires activation of the
immune system by endogenous danger signals. A recent
study showed that mice lacking the P2X7 receptor are
resistant to contact hypersensitivity. ‘‘P2X7 receptor-deficient
dendritic cells fail to induce sensitization to contact allergens
and do not release IL-1b in response to ATP or lipopoly-
saccharide’’ (Weber et al., 2010). It was concluded that the
P2X7 receptor is crucial ‘‘for extracellular ATP release in skin
in response to contact allergens’’ and it was suggested that
‘‘interference with P2X7 receptor signaling may be a
promising strategy for the prevention of allergic contact
dermatitis.’’
Wound healing
Topically applied adenosine A1 or A2A receptor agonists
promote cutaneous wound healing in full-thickness exci-
sional wounds in normal and diabetic mice and rats
(Montesinos et al., 1997; Sun et al., 1999). Evidence from
experiments performed on A2A receptor knockout mice
demonstrated that the A2A receptor is the adenosine receptor
subtype involved in wound healing (Montesinos et al., 2002).
This group found that exogenous A2A agonists increased
angiogenesis in healing wounds and endogenously released
adenosine interacted with A2A receptors to promote angio-
genesis in an internal wound (murine air pouch model)
(Montesinos et al., 2002). In a separate study, it was found
that topical treatment with adenosine promoted wound
healing via an A2B receptor (Braun et al., 2006), suggesting
that both A2A and A2B receptors are involved in the regulation
of wound healing. Adenosine A2A receptor agonists also
increased the rate of wound closure (Victor-Vega et al.,
2002). Other groups have found that the adenosine A2A
receptor promotes collagen production by dermal fibroblasts
(Chan et al., 2006).
Several studies have proposed that extracellular ATP and
ADP may play a role in wound healing (Wang et al., 1990).
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ATP, released by damaged cells and physiologically in
response to gentle mechanical disturbance, appears to be
involved in wound healing, tissue repair, and regeneration.
Direct Mg-ATP delivery to cutaneous wounds accelerates
healing, perhaps by increasing vascular endothelial growth
factor synthesis (Chiang et al., 2007). During wound healing,
release of ATP from platelets and other cells leads to a rise in
[Ca2þ ]i and InsP3 in keratinocytes, which is associated with
epidermal growth and differentiation (Pillai and Bikle, 1992).
Cutaneous wound healing involves three overlapping
phases: inflammation, tissue formation, and tissue remodel-
ing (Bello and Phillips, 2000). This process of regeneration
and repair eventually leads to scar formation. This involves a
dynamic series of events including clotting, inflammation,
granulation tissue formation, epithelialization, neovascular-
ization, collagen synthesis, and wound contraction. These
activities occur in a carefully regulated cascade that is
triggered by tissue injury. Re-epithelialization involves multi-
ple processes including the formation of a provisional wound
bed matrix, the migration of epidermal keratinocytes from the
cut edge of the wound, the proliferation of keratinocytes that
feed the advancing and migrating epithelial edge, the
stratification and differentiation of new epidermis, and the
reformation of the basement membrane zone. A recent
review discusses the therapeutic potential of purinergic
compounds as enhancers of wound healing (Gendaszews-
ka-Darmach and Kucharska, 2011).
Hemostasis. Purinergic signaling is involved in hemostasis.
ADP is a potent platelet-recruiting factor and induces platelet
aggregation via interaction with two P2 platelet receptors: the
P2Y1 receptor, which is involved in shape changes and
transient platelet aggregation, and the P2Y12 receptor, which
mediates degranulation and sustained platelet aggregation
(Gachet, 2001; Hollopeter et al., 2001). ATP is a competitive
ADP antagonist at platelet P2Y receptors and stimulates the
production of prostaglandin I2 and nitric oxide, which can
also inhibit platelet aggregation and act as vasodilators.
Exogenous ATP acts to localize thrombus formation to areas
of vascular damage, controlling the relationship between
hemostasis, thrombosis, and fibrinolysis (Burnstock and
Williams, 2000).
Acute inflammation. The initial phase of wound healing
involves acute inflammation. ATP and adenosine are both
released at sites of inflammation. ATP is involved in the
development of inflammation through a combination of
actions: release of histamine from mast cells, provoking
production of prostaglandins, and the production and release
of cytokines from immune cells (Burnstock, 2002a). Puriner-
gic receptors on immune cells are also involved in the killing
of intracellular pathogens by inducing apoptosis of host
macrophages, chemoattraction, and cell adhesion. In con-
trast, adenosine exerts anti-inflammatory actions. Adenosine
inhibits neutrophil rolling and adhesion to vascular endothe-
lium, decreases oxygen free radical production by neutro-
phils via A2A receptor activation, and also exerts effects on
endothelial cell permeability, reducing bradykinin- and
histamine-induced vascular leakage via activation of A1 and
A2A receptors (Williams and Jarvis, 2000).
Angiogenesis. Wound healing also involves new vessel
ingrowth (angiogenesis) into the wound healing matrix.
Adenosine and ATP are involved in cell migration and
proliferation during angiogenesis (Burnstock, 2002b). Ade-
nosine inhibits vascular smooth muscle cell proliferation by
A2 receptor activation (Jonzon et al., 1985; Dubey et al.,
1996). ATP and ADP stimulate DNA synthesis and cell
proliferation in cultured porcine artery smooth muscle cells
(Wang et al., 1992), and ATP is mitogenic in human vascular
smooth muscle cells (Erlinge et al., 1994). UTP also has
powerful mitogenic actions on vascular smooth muscle
(Erlinge et al., 1995; Malam-Souley et al., 1996) and it has
been suggested that P2Y2 and P2Y4 receptors might be
implicated in this (Burnstock, 2002b).
Denervated wounds and re-epithelialization.Wound healing
has been shown to be delayed in denervated wounds
(Richards et al., 1997). The mechanism for this is unknown.
It has been shown that exogenously applied nerve growth
factor has a normalizing effect on the rate of healing of
denervated wounds in a rat model, reducing the time for
wound closure. In a rat skin model of normal and delayed
wound healing after denervation, P2X5, P2X7, P2Y1, and
P2Y2 receptor expression in the epidermis was altered. P2Y1
receptor expression in the basal proliferating layer was
significantly increased in keratinocytes of the regenerating
epidermis of the denervated wounds, but P2Y2 receptors
were significantly decreased. Nerve growth factor treatment
enhanced P2X5 receptors in the suprabasal layer of the
epidermis in innervated wounds; P2X7 receptors, associated
with terminally differentiated keratinocytes in the stratum
corneum, were absent in experimental wound healing
preparations (Greig et al., 2003c). ATP and UTP, probably
via P2Y2 receptors, significantly enhanced the proliferation of
the murine keratinocyte cell line, MCS-P5, and enhanced
wound healing in mice (Braun et al., 2006). Guanosine has
also been shown to accelerate wound healing (Jiang et al.,
2006). It is claimed that ATP released from keratinocytes and
other skin cells inhibits human keratinocyte migration,
although it stimulates endothelial cell migration during
wound healing via P2Y2 receptors (Taboubi et al., 2007,
2010). Nevertheless, this does not exclude the role of ATP
and UTP in increasing keratinocyte proliferation during
wound healing reported earlier.
Barrier function. An important role of the skin is protecting
water-rich internal organs from environmental dryness, with
the stratum corneum playing a critical role as the water-
impermeable barrier. When barrier function is damaged by
surfactant, organic solvent, or tape stripping, topical applica-
tion of ATP and a,b-meATP via P2X receptors delayed barrier
recovery, whereas the P2 receptor antagonists, suramin, PPADS
(pyridoxal-phosphate-6-azophenyl-20,40-disulfonic acid), and
TNP-ATP (20,30-O-(2,4,6-trinitrophenyl)-ATP), accelerated barr-
ier repair (Denda et al., 2002). It was found that in mice, skin
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wounds healed faster when treated with the ATP-encapsu-
lated fusogenic lipid vesicles than those treated with lipid
vesicles (Chiang et al., 2007).
Burns
There are increased concentrations of adenosine, a break-
down product of ATP, in burn blister fluid (Shaked et al.,
2007). Depletion of ATP in skin after thermal injury has been
described (Carney et al., 1976). A protective effect of ATP
administration for skin burns has been reported. For example,
exogenous ATP, injected intramuscularly during the early
postburn period, restored the ATP content of the liver and
heart and modified the burn-related damage in the rat liver
(Zaki et al., 1978). Administration of ATP-MgCl2 following
burn injury reversed the impairment of intravascular clearing
of lipid emulsions by phagocytosis within the reticuloen-
dothelial immune system (Chaudry et al., 1982). ATP affected
glucose metabolism in thermally injured skin (Hershey et al.,
1971).
Pain
ATP, given systemically, elicits pain responses and endogen-
ous ATP may contribute to the pain associated with
causalgia, reflex sympathetic dystrophy, angina, migraine,
and cancer pain (Burnstock, 1996). Pain is often associated
with changes in sympathetic nerve activity. It was proposed
that ATP released as a cotransmitter with noradrenaline from
sympathetic nerves could modulate the rat cutaneous
nociceptors in various ways (Yajima et al., 2005).
P2X3 receptors are found on sensory neurons in trigeminal,
nodose, and on DRG that innervates cutaneous tissues
(Aoki et al., 2003). ‘‘Cutaneous sensory nerves were
identified in L3 and L4 DRG’’ and a subpopulation of
cutaneous afferents showed strong P2X3 immunostaining
(Zhong et al., 2003). However, ‘‘only 24% of the cutaneous
afferent nerves gave persistent currents to a,b-meATP, 66%
gave transient or biphasic currents and the remaining 10%’’
were unresponsive.
ATP and ADP were shown to stimulate afferent nerve
terminals in the skin (Bleehen, 1978) and skin cell damage
excites nociceptive sensory nerves through release of
cytosolic ATP (Cook and McCleskey, 2002). In normal rat
skin, and that inflamed with carrageenan, there is selective
activation of nociceptors by a,b-meATP, suggesting that P2X3
receptors are involved (Hamilton et al., 2001). After repetitive
heat stimulation, ATP-induced excitation was facilitated and
the authors suggested that the mechanoheat nociceptors were
being sensitized by a,b-meATP. It was proposed that ATP
plays a central role in the increased sensitivity of nociceptors
in inflamed skin, resulting in heat hyperalgesia, perhaps by
increasing [Ca2þ ]i (Kress and Guenther, 1999). Nonspecific
P2 receptor antagonists, such as suramin, are antinociceptive,
and P2X3 receptor knockout mice have reduced nociceptive
inflammatory responses (Cockayne et al., 2000). UV light led
to hypersensitivity of skin to ATP-induced pain (Burnstock
et al., 2000). Reduction of prolonged pain by PPADS, after
subcutaneous bee venom injection, was taken to suggest that
activation of P2X receptors in the spinal cord contributes to
pain (Zheng and Chen, 2000). The terminals of nociceptive
neurons in the skin and visceral organs represent unique
targets for new analgesic agents that function as P2X3
receptor antagonists.
A substantial subpopulation of P2X3 receptor expressing-
DRG neurons coexpress P2Y receptors (Ruan and Burnstock,
2003). UTP has been shown to sensitize a subpopulation of
cutaneous C-fiber nociceptors to mechanical stimuli (Lechner
and Lewin, 2009). A study of the distribution of P2X3
receptor–immunoreactive fibers in hairy and glabrous rat
skin showed P2X3 receptors on extensive nerve fibers
throughout the upper and lower epidermis (Taylor et al.,
2009) (Figure 4). Thick bands of P2X3-immunoreactive fibers
ran in parallel with the dermal–epidermal junction from
ud
epid
sg
Hairy skin (lip)
ud
Glabrous skin (paw)
epid
Figure 4. Representative photomicrographs showing P2X3 innervation in the
epidermis and upper dermis. (a) Hairy lower lip skin. P2X3-immunoreactive
fibers form a heavily reticulated pattern of innervation in the upper dermis
and epidermis. (b) Glabrous thick skin of hind paw. There was less fiber
branching within the epidermis than in hairy skin. Arrows indicate P2X3-
immunoreactive intraepidermal (or intraepithelial) fibers. epid, epidermis;
sg, sebaceous gland; ud, upper dermis. Bar¼ 50mm (reproduced from
Taylor et al., 2009, with permission from John Wiley and Sons).
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which multiple thin collateral axons penetrate the epidermal
layer creating a dense network of innervation throughout
the entire epidermis and were far more extensive than
calcitonin gene-related peptide (CGRP)-immunoreactive
fibers. P2X3-positive fibers innervated hair follicles, but
were rarely found in close proximity to glands or blood
vessels. Biopsies of the plantar skin injected with osteolytic
fibrosarcoma cells showed that ‘‘the proportion of CGRP
immunoreactive fibres that labelled for P2X3 receptors
increased from approximately 6% in control animals to
nearly 30% at day 14 following tumour cell implantation’’
(Gilchrist et al., 2005). The authors suggested that this
‘‘increased expression of P2X3 receptors on CGRP-positive
fibres during tumour growth’’ may implicate ‘‘a role for ATP
in cancer-related pain.’’
Evidence was presented that enhanced expression of glial
cell line–derived neurotrophic factor in the skin can enhance
the mechanical sensitivity of isolectin B4-positive nociceptive
afferents (Albers et al., 2006), which express P2X3 receptors
(Bradbury et al., 1998). Cutaneous sensory neurons express
mas-related G-protein-coupled receptors predominately on
small-diameter mouse DRG neurons labeled with isolectin B4
and express P2X3 receptors (Zylka et al., 2005). Evidence has
been presented that mas-related G-protein-coupled receptor-
positive neurons are nociceptors in the outer epidermis that
respond to the external stimuli by detecting ATP release in the
skin (Dussor et al., 2008).
The majority (78%) of c-Ret-positive DRG neurons express
P2X3 receptors (Kobayashi et al., 2005), whereas a similar
percentage of TRPV1-positive cells also label for P2X3
receptors (Guo et al., 1999). It has been suggested that,
‘‘apart from participation in normal thermal sensation
relevant to thermoregulation and reproductive functions,’’ a
small subpopulation of C-fibers that express high levels of
TRPV1 ‘‘may mediate burning pain in chronic pain syn-
dromes with perineal localization’’ (Kiasalari et al., 2010).
Pain from burn injuries is severe and the effects of
tetramethylpyrazine, a Chinese medicine used against period
pain and claimed to be a P2X3 receptor antagonist (Gao et al.,
2008), on burn pain mediated by P2X3 receptors has been
investigated (Gao et al., 2010). P2X3 receptor expression on
sensory nerve terminals in first- and second-degree burn-
injured skin was increased. However, after treatment with
tetramethylpyrazine, P2X3 receptor expression was signifi-
cantly decreased. P2X3 receptors have been implicated in the
short-lasting thermal hyperalgesia evoked in response to mild
heat injury (Fu¨redi et al., 2010).
Intravenous adenosine has been shown to reduce neuro-
pathic pain, hyperalgesia, and ischemic pain to a similar
degree as morphine or ketamine (Segerdahl et al., 1994) and
adenosine reduced the skin area showing hypersensitivity
after a superficial skin burn, induced with chemical irritants
or heat (Sjo¨lund et al., 1999). Ecto-50-nucleotidase (CD73) is
located on epidermal keratinocytes and nociceptive terminals
in the epidermis (Sowa et al., 2010), which, by hydrolyzing
AMP to adenosine, is claimed to be antinociceptive (Aley
et al., 1995). Clinical trials have shown that preoperative
infusion of adenosine reduced the requirement for volatile
anesthetic gas (isoflurane) and postoperative opioid use
during surgery (Segerdahl et al., 1995, 1996, 1997).
Reviews concerning purinergic signaling and pain are
available (Hamilton and McMahon, 2000; Burnstock, 2006,
2009b; Nakatsuka and Gu, 2008; Dussor et al., 2009; Zhu
and Lu, 2010).
Skin cancer
Different subtypes of P1 and P2 receptors are involved in skin
cancer, mediating proliferation, differentiaton, and apoptosis.
The role of purinoceptor involvement is complicated by the
presence of different receptor subtypes on the same cell, with
different receptors sometimes having opposite effects, e.g.,
P2Y2 receptors mediate an increase in cell numbers, whereas
P2Y1, P2X5, and P2X7 receptors mediate a decrease in cell
numbers. It would therefore seem that there is a fine balance
in the activity of the different receptor subtypes, either
mitogenic or apoptotic, in healthy skin, and that this balance
might be impaired in cancers of the skin, with proliferation far
outweighing apoptosis.
Basal cell and squamous cell carcinomas. Local administra-
tion of nucleoside analogs inhibited the growth of basal cell
carcinomas (Klein et al., 1975). The A431 human cutaneous
squamous cell carcinoma cell line expressed P2 receptors
(Hosoi and Edidin, 1989), which when occupied led to
increase in [Ca2þ ]i (Gonzalez et al., 1989; Hosoi et al.,
1992). Stimulation of A431 cells by ATP caused production of
InsP3 (Sugita et al., 1994), suggesting that P2Y receptors were
involved. Extracellular ATP, perhaps mediated by P2X
receptors, was shown to be a critical factor involved in
human lymphokine-activated killing of human carcinoma
cells (Correale et al., 1995).
Purinergic signaling was investigated in basal cell and
cutaneous squamous cell carcinomas (Greig et al., 2003d).
Immunohistochemical analysis of both frozen and paraffin
sections of these human skin carcinomas showed expression
of P2X5, P2X7, P2Y1, P2Y2, and P2Y4 receptors. P2X5 and
P2Y2 receptors were heavily expressed in both basal cell and
squamous cell carcinomas. P2X7 receptors were expressed in
the necrotic center of nodular basal cell carcinomas and in
apoptotic cells in superficial multifocal and infiltrative basal
cell carcinomas. P2Y1 receptors were only expressed on the
stroma surrounding tumors. P2Y4 receptors were found in
basal cell, but not squamous cell carcinomas. Functional
studies on the A431 squamous carcinoma cell line supported
the view that low concentrations of ATP and UTP caused an
increase in cell number, whereas high concentrations caused
a significant decrease, although the potent P2X7 receptor
agonist, BzATP, also caused a significant decrease.
In addition to ATP causing apoptosis of cultured A431
cells via P2X7 receptors (Figure 5), it was shown that UTP and
adenosine (following breakdown of ATP) also induced cell
death (Vo¨lkl et al., 2008). Skin neoplasias in mice (papillomas
and squamous spindle-cell carcinomas) were induced by
local treatment with 7,12-dimethyl-benz(a)anthracene
(DMBA), followed by tumor promotion with 12-O-tetra-
decanoylphorbol-13-acetate (TPA). Application of BzATP, a
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potent P2X7 receptor agonist, inhibited the formation of
DMBA/TPA-induced skin papillomas and carcinomas (Fu
et al., 2009). At the completion of the study at week 28,
100% of living animals in the DMBA/TPA group had cancers
compared with 43% in the DMBA/TPAþBzATP group. The
BzATP-induced apoptosis could be blocked by cotreatment
with inhibitors of caspase-9 and caspase-3, but not of
caspase-8.
In conclusion, P2Y2 receptors mediate proliferation, P2X5
receptors mediate differentiation, and P2X7 receptors mediate
cell death in nonmelanoma skin cancers.
Melanoma.Malignant melanoma is an aggressive cancer that
originates from melanocytes. ATP inhibited the growth of
both animal and human melanoma cells (Rapaport, 1983;
Kitagawa et al., 1988; Mure et al., 1992). Extracellular ATP
has growth-inhibiting properties in a highly metastatic liver-
colonizing murine B16 melanoma cell line in vitro (Palo-
mares et al., 1999). Ecto-ATP diphosphohydrolase (CD39) ‘‘is
overexpressed in differentiated human melanomas compared
to normal melanocytes’’ (Dzhandzhugazyan et al., 1998).
ATP released by murine B16 melanoma cells upregulate the
expression of ecto-nucleotidase (CD39) on tumor-resistant
regulating T cells; the upregulated CD39 degrades ATP to
adenosine, which then contributes to the immunosuppressive
environment of the tumor (Kretz et al., 2009).
Increased expression of P2X7 receptors in 80 cases of
superficial spreading melanomas was reported (Slater et al.,
2003). Labeling of P2X receptors also extended 2 mm from the
melanoma into the keratinocyte layer of the adjacent
epidermis. Conversely, P2X13 and P2Y2 receptors (found
on normal, but not neoplastic skin) were fully de-expressed
within 2 mm of the melanoma (Slater et al., 2003). Another
paper confirmed that human melanomas express functional
P2X7 receptors, which cause apoptosis, and it was suggested
that they may represent a new target for melanoma therapy
(White et al., 2005a). Expression of P2Y1, P2Y2, and P2Y6
receptor mRNA and protein in human melanomas was
reported (White et al., 2005b). This study also showed that
incubation of A375 melanoma cells with the P2Y1 agonist,
2-methylthio ADP, caused a dose-dependent decrease in cell
number, whereas the P2Y2 receptor agonist, UTP, caused an
increase in cell numbers. The presence of multiple P2
receptor subtypes on different cell types is common (see
Burnstock and Knight, 2004) where they often mediate
different physiological effects; thus, the presence of two
P2Y receptors on melanoma cells mediating opposite effects
on cell growth increases the number of targets available for
therapeutic intervention.
Melanoma is characterized by apoptosis resistance con-
nected to irradiation- and chemo-resistance, and it was
claimed that the P2X7 receptor has an antiapoptotic function
in melanoma cells, as ATP activation suppresses induced
apoptosis, whereas with knockdown of P2X7 receptor gene
expression, ATP-induced apoptosis was enhanced (Deli et al.,
2007). A later paper has shown that g-irradiation, which
causes growth arrest and death of tumor cells, induces P2X7
receptor–dependent ATP release from murine B16 melanoma
cells (Ohshima et al., 2010).
Athymic mice, injected with A375 human melanoma
cells, were treated daily with intraperitoneal injections of
ATP. The tumor volume, animal weight, and the final tumor
nodule weight were measured over the course of the
experiment. Tumor volume decreased by nearly 50% after
7 weeks in treated mice. Weight loss in untreated animals
was prevented by ATP (Figure 6). Histological examination of
the excised tumor nodules showed necrosis in the ATP-
treated tumors only. The presence of P2Y1 and P2X7
receptors, previously proposed as extracellular targets for
melanoma treatment with ATP, were demonstrated in the
excised specimens by immunohistochemistry. This paper
provides further support for the use of ATP as a treatment for
melanoma (White et al., 2009).
Adenosine has also been investigated in relation to
melanomas. For example, administration of adenosine was
shown to potentiate the actions of chemotherapeutic agents
in vivo. In mice inoculated with B16 melanoma cells,
adenosine (5mM) was injected 5 days before administration
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Figure 5. Change in the cell number of squamous cell carcinoma, A431
cells, at 48 hours after adenosine 50-triphosphate (ATP) application. At
48 hours after application, low doses of ATP (10 mM) caused an increase in cell
number, whereas high doses of ATP (1,000–5,000 mM; Po0.001) caused a
significant decrease. Results represent the mean of 26 experiments. *Po0.001
compared with control (following one-way analysis of variance Bonferroni’s
multiple comparison test). Error bars represent mean±SEM. These effects
were also shown by the colony size and cell morphology. A431 cells were
stained with crystal violet and phase contrast micrographs were taken.
(a) Control—cells grown in A431 medium only; (b) 10 mM ATP caused
colonies of A431 cells to appear visibly larger than in control wells;
(c) 100mM ATP caused no change in the colony size; (d) 1,000 mM ATP and
(e) 5,000 mM ATP both caused a marked decrease in colony size, with cells
rounding up and dying in 5,000 mM ATP; scale bar¼ 150 mm (reproduced
from Greig et al., 2003d, with permission of the Nature Publishing Group).
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of cyclophosphamide (50mg kg–1). This combined treatment
reduced the number of melanoma foci by 60%, whereas the
chemotherapy alone only reduced them by 45%. Moreover, a
protective effect of adenosine against chemotherapy-induced
decrease in leukocyte counts was seen in this study (Fishman
and Bar-Yehuda, 1998). Cell motility, an essential compo-
nent of tumor progression and metastasis, is mediated by
adenosine in human melanoma cells, probably via the A1
receptor subtype and the possibility of antimetastatic
therapies based on inhibition of A1 receptor activation was
raised (Woodhouse et al., 1998). A1, A2A, A2B, and A3
receptor subtypes were all identified in the human malignant
melanoma A375 cell line with reverse transcription-PCR and
pharmacological evidence (Merighi et al., 2001). Adenosine
arising from released ATP acting on adenosine receptors
mediates both reduction of cell proliferation (probably via A3
receptors) and promotion of cell death (probably via A2A
receptors) of cultured human melanoma A375 cells (Merighi
et al., 2002). A later paper confirmed that A3 receptor
activation led to growth inhibition of melanoma cells and
showed that this occurs both in vitro and in vivo (Madi et al.,
2003). A3 receptor activation inhibits cell proliferation via
phosphatidylositol 3-kinase 1/2 phosphorylation in A375
human melanoma cells (Merighi et al., 2005). A2B receptor
blockade can impair IL-8 production, which is elevated in
patients with malignant melanoma, whereas blocking A3
receptors decreases vascular endothelial growth factor,
which promotes angiogenesis and metastasis of human
carcinoma cells (Merighi et al., 2009). A review of adenosine
receptors and human melanoma was published in 2003
(Merighi et al., 2003).
POTENTIAL THERAPEUTIC STRATEGIES
There are many potential therapeutic uses of purine and
pyrimidine compounds. Adenosine (and guanosine) promote
cutaneous wound healing in normal and diabetic conditions
(Montesinos et al., 1997; Sun et al., 1999; Jiang et al., 2006),
as well as wound closure (Victor-Vega et al., 2002).
Adenosine antagonists may have a therapeutic role in the
treatment and prevention of dermal fibrosis in scleroderma
(Chan et al., 2006; Ferna´ndez et al., 2008; Chan and
Cronstein, 2010). Adenosine has been used as a topical
application to reduce wrinkles (Legendre et al., 2007)
perhaps by promoting collagen production by dermal
fibroblasts (Chan et al., 2006). It may also have a therapeutic
application in hair loss (Oura et al., 2008; Iwabuchi et al.,
2009).
There are also many potential roles for ATP and related
compounds. Antagonists to P2 receptors reduce inflammatory
conditions (Inoue et al., 2007), whereas P2Y2 receptor
agonists may provide a new therapy for psoriasis (Dixon
et al., 1999). ATP, in addition to adenosine, may have
beneficial effects on wound healing, inhibiting human
keratinoctye migration while stimulating endothelial cell
migration (Taboubi et al., 2007, 2010). Direct Mg-ATP
delivery accelerates healing of cutaneous wounds (Chiang
et al., 2007). ATP improves ischemic skin flap survival
following surgery (Boss et al., 1984; Cikrit et al., 1984;
Zimmerman et al., 1987; Knight et al., 1989). In contrast, the
P2 receptor antagonists, suramin, PPADS, and TNP-ATP,
accelerate barrier repair (Denda et al., 2002).
Of particular importance is a therapeutic role for
adenosine and ATP in the treatment of cancer. ATP as a
treatment for melanoma has been proposed (White et al.,
2009). Of special interest is the P2X7 receptor, as P2X7
receptor agonists decrease significantly A431 cutaneous
squamous cell carcinoma cells in culture (Greig et al.,
2003a, d) and inhibit the formation of chemically induced
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Figure 6. Athymic mice injected with A375 human melanoma cells, treated
daily with intraperitoneal injections of adenosine 50-triphosphate (ATP).
(a) The weight of the untreated group of animals decreased over the 6-week
course of the experiment from a mean of 30 g to a mean of 28.2 g. However,
in the treated group, the weight of the animals increased from a mean of
30 g to 31.8 g. There was a statistically significant difference in the weight
of the animals over the course of the experiment (**P¼0.0038). (b) There was
a statistically significant reduction in tumor volume in the treated group
compared with the untreated group (*P¼0.0163). Tumors in both the
treated and untreated groups continued to grow during the course of the
experiment but the rate of growth of the untreated group was much higher
than that of the treated group. (c) At the end of the experiment the tumor
nodules were excised and weighed. There was a statistically significant
reduction in final tumor weight in the treated group compared with the
untreated group (*P¼ 0.0156). The mean weight of tumors was 1.92±0.31 g
(n¼10) in the untreated group as compared with 1.15±0.24 g (n¼ 10)
in the treated group. Statistical significance was tested by analysis of variance
tests (reproduced from White et al., 2009, with permission of Springer).
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skin papillomas and carcinomas (Fu et al., 2009). Similarly,
agonists for the P2Y1 receptors also reduce cancer cell
numbers in vitro (Greig et al., 2003a). Adenosine can
potentiate the actions of chemotherapeutic agents in vivo
(Fishman and Bar-Yehuda, 1998), and another area that is
potentially promising in the development of purine-based
therapies is using ATP or a compound that is subtype specific
in tandem with established cytotoxic agents.
SUMMARY
There are an increasing number of studies concerned with the
therapeutic applications of purinergic signaling in the skin.
This review summarizes knowledge of the roles of purinergic
receptors in healthy skin and lays the foundations for an
understanding of current studies of the involvement of
purinergic receptors in the pathology of skin, including hair
growth, wound healing, pain, inflammation, allergic derma-
titis, and both melanoma and nonmelanoma skin cancer.
Purinergic receptor biology may open a pathway for new
treatment modalities in these important skin conditions.
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